EUVIMEDEUVIMED entdecken
Open Access

What makes Candida auris pan-drug resistant? Integrative insights from genomic, transcriptomic, and phenomic analysis of clinical strains resistant to all four major classes of antifungal drugs

Johanna Rhodes, Jonathan Jacobs iD, Emily K Dennis iD, Swati R Manjari, Nilesh K Banavali, Robert Marlow, Mohammed Anower Rokebul, Sudha Chaturvedi iD, Vishnu Chaturvedi iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.00911-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Johanna Rhodes und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Radboudumc, Nijmegen, the Netherlands. Hauptthemen laut MEDLINE: Antifungal Agents, Microbial Sensitivity Tests, Candida auris, Drug Resistance, Multiple, Fungal. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, NIAID NIH HHS, NCEZID CDC HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The global epidemic of drug-resistant Candida auris continues unabated. The initial report on pan-drug resistant (PDR) C. auris strains in a hospitalized patient in New York was unprecedented. PDR C. auris showed both known and unique mutations in the prominent gene targets of azoles, amphotericin B, echinocandins, and flucytosine. However, the factors that allow C. auris to acquire pan-drug resistance are not known. Therefore, we conducted a genomic, transcriptomic, and phenomic analysis to better understand PDR C. auris . Among 1,570 genetic variants in drug-resistant C. auris , 299 were unique to PDR strains. The whole-genome sequencing results suggested perturbations in genes associated with nucleotide biosynthesis, mRNA processing, and nuclear export of mRNA. Whole transcriptome sequencing of PDR C. auris revealed two genes to be significantly differentially expressed—a DNA repair protein and DNA replication-dependent chromatin assembly factor 1. Of 59 novel transcripts, 12 transcripts had no known homology. We observed no fitness defects among multi-drug resistant (MDR) and PDR C. auris strains grown in nutrient-deficient or -enriched media at different temperatures. Phenotypic profiling revealed wider adaptability to nitrogenous nutrients and increased utilization of substrates critical in upper glycolysis and tricarboxylic acid cycle. Structural modeling of a 33-amino acid deletion in the gene for uracil phosphoribosyl transferase suggested an alternate route in C. auris to generate uracil monophosphate that does not accommodate 5-fluorouracil as a substrate. Overall, we find evidence of metabolic adaptations in MDR and PDR C. auris in response to antifungal drug lethality without deleterious fitness costs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antifungal AgentsMicrobial Sensitivity TestsCandida aurisDrug Resistance, Multiple, FungalHumansTranscriptomeWhole Genome SequencingFlucytosineAmphotericin BEchinocandinsAzolesCandidiasisGenomics

Stichwörter der Autor:innen

5-flucytosineRNAseqamphotericin Bazolesechinocandinsmodelingphenotyping

Substanzen

Antifungal AgentsFlucytosineAmphotericin BEchinocandinsAzoles

Autor:innen und Institutionen

  • Department of Medical Microbiology, Radboudumc, Nijmegen, the Netherlands.
  • MRC GIDA, Imperial College London, London, United Kingdom.
  • American Type Culture Collection, University Blvd, Manassas, Virginia, USA.
  • Wadsworth Center, New York State Department of Health, Albany, New York, USA.
  • School of Public Health, University of Albany, Albany, New York, USA.
  • Westchester Medical Center/New York Medical College, Valhalla, New York, USA.

ORCID-Profile: Jonathan Jacobs, Emily K Dennis, Sudha Chaturvedi, Vishnu Chaturvedi

Förderung

  • Wellcome Trust
  • NIAID NIH HHS
  • NCEZID CDC HHS

Zitieren

APA

Rhodes, J., Jacobs, J., Dennis, E. K., Manjari, S. R., Banavali, N. K., Marlow, R., Rokebul, M. A., Chaturvedi, S., & Chaturvedi, V. (2024). What makes Candida auris pan-drug resistant? Integrative insights from genomic, transcriptomic, and phenomic analysis of clinical strains resistant to all four major classes of antifungal drugs. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00911-24

Vancouver

Rhodes J, Jacobs J, Dennis EK, Manjari SR, Banavali NK, Marlow R, et al. What makes Candida auris pan-drug resistant? Integrative insights from genomic, transcriptomic, and phenomic analysis of clinical strains resistant to all four major classes of antifungal drugs. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00911-24

BibTeX
@article{Rhodes2024,
  author = {Rhodes, Johanna and Jacobs, Jonathan and Dennis, Emily K and Manjari, Swati R and Banavali, Nilesh K and Marlow, Robert and Rokebul, Mohammed Anower and Chaturvedi, Sudha and Chaturvedi, Vishnu},
  title = {What makes Candida auris pan-drug resistant? Integrative insights from genomic, transcriptomic, and phenomic analysis of clinical strains resistant to all four major classes of antifungal drugs},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.00911-24}
}
Kostenlos starten →